SynAct Pharma AB (SYNACT) — Financial Flexibility Index
SynAct Pharma AB (SYNACT) has a Financial Flexibility Index of -0.75x as of March 2026. Free cash flow of Skr-32.95 Million (operating CF Skr-32.95 Million minus capex Skr0.00) represents -1% of total liabilities (Skr44.13 Million). Check SYNACT strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
SynAct Pharma AB Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for SynAct Pharma AB across 10 annual periods. See working capital to net assets of SynAct Pharma AB to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for SynAct Pharma AB (2016–2025)
Year-by-year free cash flow to debt coverage for SynAct Pharma AB. For the full company profile including market capitalisation, see market cap of SynAct Pharma AB.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.94x | Skr-97.33 Million | Skr-97.33 Million | Skr50.23 Million | ▼ -22.4% |
| 2024 | -1.58x | Skr-89.20 Million | Skr-89.20 Million | Skr56.35 Million | ▲ +18.1% |
| 2023 | -1.93x | Skr-100.18 Million | Skr-100.18 Million | Skr51.83 Million | ▲ +73.6% |
| 2022 | -7.31x | Skr-117.56 Million | Skr-117.56 Million | Skr16.08 Million | ▼ -96.9% |
| 2021 | -3.71x | Skr-65.00 Million | Skr-65.00 Million | Skr17.50 Million | ▼ -2126230.4% |
| 2020 | 0.00x | Skr-1.00K | Skr-33.24 Million | Skr5.72 Million | ▲ +100.0% |
| 2019 | -1.52x | Skr-15.62 Million | Skr-16.12 Million | Skr10.31 Million | ▲ +76.7% |
| 2018 | -6.52x | Skr-24.21 Million | Skr-24.21 Million | Skr3.72 Million | ▲ +11.0% |
| 2017 | -7.32x | Skr-16.94 Million | Skr-17.20 Million | Skr2.31 Million | ▼ -84.9% |
| 2016 | -3.96x | Skr-13.83 Million | Skr-14.73 Million | Skr3.49 Million | — |